Clinical Trial Update: Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a targeted anti-CEA CAR-T immunotherapy in patients with advanced lung cancer, sponsored by Chongqing Precision Biotech Co., L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Targeted Anti-CEA CAR-T Immunotherapy

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Advanced Lung Cancer | Phase 1 | Status: RECRUITING